213 related articles for article (PubMed ID: 12677022)
1. Contribution of 5-hydroxytryptamine1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage.
Cambj-Sapunar L; Yu M; Harder DR; Roman RJ
Stroke; 2003 May; 34(5):1269-75. PubMed ID: 12677022
[TBL] [Abstract][Full Text] [Related]
2. 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat.
Kehl F; Cambj-Sapunar L; Maier KG; Miyata N; Kametani S; Okamoto H; Hudetz AG; Schulte ML; Zagorac D; Harder DR; Roman RJ
Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1556-65. PubMed ID: 11893593
[TBL] [Abstract][Full Text] [Related]
3. Effects of a 20-HETE antagonist and agonists on cerebral vascular tone.
Yu M; Cambj-Sapunar L; Kehl F; Maier KG; Takeuchi K; Miyata N; Ishimoto T; Reddy LM; Falck JR; Gebremedhin D; Harder DR; Roman RJ
Eur J Pharmacol; 2004 Feb; 486(3):297-306. PubMed ID: 14985052
[TBL] [Abstract][Full Text] [Related]
4. Reversal of delayed vasospasm by an inhibitor of the synthesis of 20-HETE.
Takeuchi K; Renic M; Bohman QC; Harder DR; Miyata N; Roman RJ
Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H2203-11. PubMed ID: 15964920
[TBL] [Abstract][Full Text] [Related]
5. Improvement in neurological outcome and abolition of cerebrovascular endothelin B and 5-hydroxytryptamine 1B receptor upregulation through mitogen-activated protein kinase kinase 1/2 inhibition after subarachnoid hemorrhage in rats.
Larsen CC; Povlsen GK; Rasmussen MN; Edvinsson L
J Neurosurg; 2011 Apr; 114(4):1143-53. PubMed ID: 20597604
[TBL] [Abstract][Full Text] [Related]
6. Reversal of delayed vasospasm by TS-011 in the dual hemorrhage dog model of subarachnoid hemorrhage.
Hacein-Bey L; Harder DR; Meier HT; Varelas PN; Miyata N; Lauer KK; Cusick JF; Roman RJ
AJNR Am J Neuroradiol; 2006; 27(6):1350-4. PubMed ID: 16775295
[TBL] [Abstract][Full Text] [Related]
7. Identification and quantification of the hydroxyeicosatetraenoic acids, 20-HETE and 12-HETE, in the cerebrospinal fluid after subarachnoid hemorrhage.
Poloyac SM; Reynolds RB; Yonas H; Kerr ME
J Neurosci Methods; 2005 Jun; 144(2):257-63. PubMed ID: 15910986
[TBL] [Abstract][Full Text] [Related]
8. ERK1/2 inhibition attenuates cerebral blood flow reduction and abolishes ET(B) and 5-HT(1B) receptor upregulation after subarachnoid hemorrhage in rat.
Beg SA; Hansen-Schwartz JA; Vikman PJ; Xu CB; Edvinsson LI
J Cereb Blood Flow Metab; 2006 Jun; 26(6):846-56. PubMed ID: 16251886
[TBL] [Abstract][Full Text] [Related]
9. Nimodipine attenuation of early brain dysfunctions is partially related to its inverting acute vasospasm in a cisterna magna subarachnoid hemorrhage (SAH) model in rats.
Zhao WJ; Wu C
Int J Neurosci; 2012 Oct; 122(10):611-7. PubMed ID: 22694164
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobin, NO, and 20-HETE interactions in mediating cerebral vasoconstriction following SAH.
Takeuchi K; Miyata N; Renic M; Harder DR; Roman RJ
Am J Physiol Regul Integr Comp Physiol; 2006 Jan; 290(1):R84-9. PubMed ID: 16166205
[TBL] [Abstract][Full Text] [Related]
11. Evidence that 20-HETE contributes to the development of acute and delayed cerebral vasospasm.
Roman RJ; Renic M; Dunn KM; Takeuchi K; Hacein-Bey L
Neurol Res; 2006 Oct; 28(7):738-49. PubMed ID: 17164037
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C inhibition prevents upregulation of vascular ET(B) and 5-HT(1B) receptors and reverses cerebral blood flow reduction after subarachnoid haemorrhage in rats.
Beg SS; Hansen-Schwartz JA; Vikman PJ; Xu CB; Edvinsson LI
J Cereb Blood Flow Metab; 2007 Jan; 27(1):21-32. PubMed ID: 16736053
[TBL] [Abstract][Full Text] [Related]
13. Neurokinin-1 receptor antagonism in a rat model of subarachnoid hemorrhage: prevention of upregulation of contractile ETB and 5-HT1B receptors and cerebral blood flow reduction.
Ansar S; Svendgaard NA; Edvinsson L
J Neurosurg; 2007 May; 106(5):881-6. PubMed ID: 17542534
[TBL] [Abstract][Full Text] [Related]
14. Cerebrovascular ETB, 5-HT1B, and AT1 receptor upregulation correlates with reduction in regional CBF after subarachnoid hemorrhage.
Ansar S; Vikman P; Nielsen M; Edvinsson L
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3750-8. PubMed ID: 17873013
[TBL] [Abstract][Full Text] [Related]
15. Equal contribution of increased intracranial pressure and subarachnoid blood to cerebral blood flow reduction and receptor upregulation after subarachnoid hemorrhage. Laboratory investigation.
Ansar S; Edvinsson L
J Neurosurg; 2009 Nov; 111(5):978-87. PubMed ID: 19408972
[TBL] [Abstract][Full Text] [Related]
16. CaMKII inhibition with KN93 attenuates endothelin and serotonin receptor-mediated vasoconstriction and prevents subarachnoid hemorrhage-induced deficits in sensorimotor function.
Edvinsson L; Povlsen GK; Ahnstedt H; Waldsee R
J Neuroinflammation; 2014 Dec; 11():207. PubMed ID: 25498987
[TBL] [Abstract][Full Text] [Related]
17. Emergence of a R-type Ca2+ channel (CaV 2.3) contributes to cerebral artery constriction after subarachnoid hemorrhage.
Ishiguro M; Wellman TL; Honda A; Russell SR; Tranmer BI; Wellman GC
Circ Res; 2005 Mar; 96(4):419-26. PubMed ID: 15692089
[TBL] [Abstract][Full Text] [Related]
18. Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats.
Dunn KM; Renic M; Flasch AK; Harder DR; Falck J; Roman RJ
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2455-65. PubMed ID: 18952718
[TBL] [Abstract][Full Text] [Related]
19. Early events triggering delayed vasoconstrictor receptor upregulation and cerebral ischemia after subarachnoid hemorrhage.
Povlsen GK; Johansson SE; Larsen CC; Samraj AK; Edvinsson L
BMC Neurosci; 2013 Mar; 14():34. PubMed ID: 23496889
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke.
Miyata N; Seki T; Tanaka Y; Omura T; Taniguchi K; Doi M; Bandou K; Kametani S; Sato M; Okuyama S; Cambj-Sapunar L; Harder DR; Roman RJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):77-85. PubMed ID: 15831442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
